MED1是一种新型的人类甲基化CpG结合核酸内切酶，它与DNA错配修复蛋白MLH1相互作用。
MED1, a novel human methyl-CpG-binding endonuclease, interacts with DNA mismatch repair protein MLH1.
作者信息
Bellacosa A, Cicchillitti L, Schepis F, Riccio A, Yeung A T, Matsumoto Y, Golemis E A, Genuardi M, Neri G
机构信息
Divisions of Population Science, Fox Chase Cancer Center, 7701 Burholme Avenue, Philadelphia, PA 19111, USA.
出版信息
Proc Natl Acad Sci U S A. 1999 Mar 30;96(7):3969-74. doi: 10.1073/pnas.96.7.3969.
Abstract
The DNA mismatch repair (MMR) is a specialized system, highly conserved throughout evolution, involved in the maintenance of genomic integrity. To identify novel human genes that may function in MMR, we employed the yeast interaction trap. Using the MMR protein MLH1 as bait, we cloned MED1. The MED1 protein forms a complex with MLH1, binds to methyl-CpG-containing DNA, has homology to bacterial DNA repair glycosylases/lyases, and displays endonuclease activity. Transfection of a MED1 mutant lacking the methyl-CpG-binding domain (MBD) is associated with microsatellite instability (MSI). These findings suggest that MED1 is a novel human DNA repair protein that may be involved in MMR and, as such, may be a candidate eukaryotic homologue of the bacterial MMR endonuclease, MutH. In addition, these results suggest that cytosine methylation may play a role in human DNA repair.
摘要
DNA错配修复（MMR）是一个在整个进化过程中高度保守的特殊系统，参与基因组完整性的维持。为了鉴定可能在MMR中发挥作用的新型人类基因，我们采用了酵母相互作用陷阱技术。以MMR蛋白MLH1作为诱饵，我们克隆出了MED1。MED1蛋白与MLH1形成复合物，结合含有甲基化CpG的DNA，与细菌DNA修复糖基化酶/裂解酶具有同源性，并表现出核酸内切酶活性。转染缺乏甲基化CpG结合结构域（MBD）的MED1突变体与微卫星不稳定性（MSI）相关。这些发现表明，MED1是一种新型的人类DNA修复蛋白，可能参与MMR，因此可能是细菌MMR核酸内切酶MutH的候选真核同源物。此外，这些结果表明胞嘧啶甲基化可能在人类DNA修复中发挥作用。
相似文献
1
MED1, a novel human methyl-CpG-binding endonuclease, interacts with DNA mismatch repair protein MLH1.MED1是一种新型的人类甲基化CpG结合核酸内切酶，它与DNA错配修复蛋白MLH1相互作用。
Proc Natl Acad Sci U S A. 1999 Mar 30;96(7):3969-74. doi: 10.1073/pnas.96.7.3969.
2
Alterations in PMS2, MSH2 and MLH1 expression in human prostate cancer.人前列腺癌中PMS2、MSH2和MLH1表达的改变。
Int J Oncol. 2003 May;22(5):1033-43.
3
Biphasic kinetics of the human DNA repair protein MED1 (MBD4), a mismatch-specific DNA N-glycosylase.人类DNA修复蛋白MED1（MBD4）的双相动力学，一种错配特异性DNA N-糖基化酶。
J Biol Chem. 2000 Oct 20;275(42):32422-9. doi: 10.1074/jbc.M004535200.
4
Human MutL homolog (MLH1) function in DNA mismatch repair: a prospective screen for missense mutations in the ATPase domain.人MutL同源物（MLH1）在DNA错配修复中的功能：ATP酶结构域错义突变的前瞻性筛查
Nucleic Acids Res. 2004 Oct 8;32(18):5321-38. doi: 10.1093/nar/gkh855. Print 2004.
5
Truncation of the C-terminus of human MLH1 blocks intracellular stabilization of PMS2 and disrupts DNA mismatch repair.人源MLH1 C末端的截短会阻碍PMS2在细胞内的稳定，并破坏DNA错配修复。
DNA Repair (Amst). 2006 Mar 7;5(3):347-61. doi: 10.1016/j.dnarep.2005.11.001. Epub 2005 Dec 9.
6
Defects of DNA mismatch repair in human prostate cancer.人类前列腺癌中DNA错配修复缺陷
Cancer Res. 2001 May 15;61(10):4112-21.
7
Use of molecular tumor characteristics to prioritize mismatch repair gene testing in early-onset colorectal cancer.利用分子肿瘤特征对早发性结直肠癌错配修复基因检测进行优先级排序。
J Clin Oncol. 2005 Sep 20;23(27):6524-32. doi: 10.1200/JCO.2005.04.671. Epub 2005 Aug 22.
8
Mismatch repair gene expression defects contribute to microsatellite instability in ovarian carcinoma.错配修复基因表达缺陷导致卵巢癌中的微卫星不稳定。
Cancer. 2003 Nov 15;98(10):2199-206. doi: 10.1002/cncr.11770.
9
Human mismatch-repair protein MutL homologue 1 (MLH1) interacts with Escherichia coli MutL and MutS in vivo and in vitro: a simple genetic system to assay MLH1 function.人类错配修复蛋白MutL同源物1（MLH1）在体内和体外均与大肠杆菌MutL和MutS相互作用：一种用于检测MLH1功能的简单遗传系统。
Biochem J. 2003 Apr 1;371(Pt 1):183-9. doi: 10.1042/BJ20021205.
10
Biallelic somatic inactivation of the mismatch repair gene MLH1 in a primary skin melanoma.原发性皮肤黑色素瘤中错配修复基因MLH1的双等位基因体细胞失活
Genes Chromosomes Cancer. 2003 Jun;37(2):165-75. doi: 10.1002/gcc.10193.
引用本文的文献
1
Protein-Protein Interactions in Base Excision Repair.碱基切除修复中的蛋白质-蛋白质相互作用
Biomolecules. 2025 Jun 18;15(6):890. doi: 10.3390/biom15060890.
2
Prognostic Significance of Polymorphism rs140693 and Clinical Characteristics in Chinese Lung Cancer Patients.中国肺癌患者中rs140693多态性的预后意义及临床特征
Phenomics. 2024 Oct 8;4(5):453-464. doi: 10.1007/s43657-024-00171-z. eCollection 2024 Oct.
3
Mutational disparities in colorectal cancers of White Americans, Alabama African Americans, And Oklahoma American Indians.美国白人、阿拉巴马非裔美国人及俄克拉荷马美洲印第安人大肠癌的突变差异
NPJ Precis Oncol. 2024 Dec 23;8(1):288. doi: 10.1038/s41698-024-00782-9.
4
Novel insights into tumorigenesis revealed by molecular analysis of Lynch syndrome cases with multiple colorectal tumors.通过对患有多发性结直肠癌的林奇综合征病例进行分子分析揭示的肿瘤发生新见解。
Front Oncol. 2024 Apr 25;14:1378392. doi: 10.3389/fonc.2024.1378392. eCollection 2024.
5
Integrated mutational landscape analysis of poorly differentiated high-grade neuroendocrine carcinoma of the uterine cervix.整合分析宫颈低分化高级别神经内分泌癌的突变特征。
Proc Natl Acad Sci U S A. 2024 Apr 23;121(17):e2321898121. doi: 10.1073/pnas.2321898121. Epub 2024 Apr 16.
6
MBD4 loss results in global reactivation of promoters and retroelements with low methylated CpG density.MBD4 缺失导致甲基化 CpG 密度低的启动子和反转录元件的全局重新激活。
J Exp Clin Cancer Res. 2023 Nov 14;42(1):301. doi: 10.1186/s13046-023-02882-z.
7
Base Excision DNA Repair in Plants: and Beyond.植物中的碱基切除修复：及超越。
Int J Mol Sci. 2023 Sep 29;24(19):14746. doi: 10.3390/ijms241914746.
8
Comparison of the pCR Rate and DFS Among Breast Cancer Patients with Different Hormone Receptor and HER2 Statuses.不同激素受体和HER2状态的乳腺癌患者的病理完全缓解率和无病生存期比较
Breast Cancer (Dove Med Press). 2023 May 1;15:327-335. doi: 10.2147/BCTT.S407896. eCollection 2023.
9
Active DNA demethylation-The epigenetic gatekeeper of development, immunity, and cancer.活性DNA去甲基化——发育、免疫和癌症的表观遗传守门人。
Adv Genet (Hoboken). 2020 Nov 27;2(1):e10033. doi: 10.1002/ggn2.10033. eCollection 2021 Mar.
10
Cytidine analogs are synthetic lethal with base excision repair default due to MBD4 deficiency.胞苷类似物因MBD4缺陷导致碱基切除修复缺陷而具有合成致死性。
NPJ Precis Oncol. 2022 Nov 2;6(1):81. doi: 10.1038/s41698-022-00326-z.
本文引用的文献
1
Replication errors: cha(lle)nging the genome.复制错误：挑战基因组。 （注：原文中“cha(lle)nging”拼写有误，正确应为“challenging”）
EMBO J. 1998 Nov 16;17(22):6427-36. doi: 10.1093/emboj/17.22.6427.
2
Identification and characterization of a family of mammalian methyl-CpG binding proteins.一类哺乳动物甲基化CpG结合蛋白家族的鉴定与特性分析。
Mol Cell Biol. 1998 Nov;18(11):6538-47. doi: 10.1128/MCB.18.11.6538.
3
DNA hypomethylation leads to elevated mutation rates.DNA低甲基化导致突变率升高。
Nature. 1998 Sep 3;395(6697):89-93. doi: 10.1038/25779.
4
Akt activation by growth factors is a multiple-step process: the role of the PH domain.生长因子介导的Akt激活是一个多步骤过程：PH结构域的作用。
Oncogene. 1998 Jul 23;17(3):313-25. doi: 10.1038/sj.onc.1201947.
5
A naturally occurring hPMS2 mutation can confer a dominant negative mutator phenotype.一种天然存在的人源PMS2突变可导致显性负性突变表型。
Mol Cell Biol. 1998 Mar;18(3):1635-41. doi: 10.1128/MCB.18.3.1635.
6
Germ-line mutation of the hMSH6/GTBP gene in an atypical hereditary nonpolyposis colorectal cancer kindred.一个非典型遗传性非息肉病性结直肠癌家系中hMSH6/GTBP基因的种系突变。
Cancer Res. 1997 Sep 15;57(18):3920-3.
7
A component of the transcriptional repressor MeCP1 shares a motif with DNA methyltransferase and HRX proteins.转录抑制因子MeCP1的一个组件与DNA甲基转移酶和HRX蛋白共享一个基序。
Nat Genet. 1997 Jul;16(3):256-9. doi: 10.1038/ng0797-256.
8
DNA methylation and genetic instability in colorectal cancer cells.结直肠癌细胞中的DNA甲基化与基因不稳定
Proc Natl Acad Sci U S A. 1997 Mar 18;94(6):2545-50. doi: 10.1073/pnas.94.6.2545.
9
MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin.甲基化CpG结合蛋白2（MeCP2）是一种转录抑制因子，在基因组染色质中具有丰富的结合位点。
Cell. 1997 Feb 21;88(4):471-81. doi: 10.1016/s0092-8674(00)81887-5.
10
Cancer of the microsatellite mutator phenotype.微卫星突变体表型癌症
Biol Chem. 1996 Nov;377(11):675-84.
Zotero 插件